WO2019194475A1 - Seringue pour injecter une substance thérapeutique - Google Patents

Seringue pour injecter une substance thérapeutique Download PDF

Info

Publication number
WO2019194475A1
WO2019194475A1 PCT/KR2019/003703 KR2019003703W WO2019194475A1 WO 2019194475 A1 WO2019194475 A1 WO 2019194475A1 KR 2019003703 W KR2019003703 W KR 2019003703W WO 2019194475 A1 WO2019194475 A1 WO 2019194475A1
Authority
WO
WIPO (PCT)
Prior art keywords
syringe
syringe assembly
therapeutic material
barrel
injecting
Prior art date
Application number
PCT/KR2019/003703
Other languages
English (en)
Korean (ko)
Inventor
이준욱
Original Assignee
이준욱
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이준욱 filed Critical 이준욱
Publication of WO2019194475A1 publication Critical patent/WO2019194475A1/fr

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • A61M5/2053—Media being expelled from injector by pressurised fluid or vacuum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/3129—Syringe barrels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/3148—Means for causing or aiding aspiration or plunger retraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
    • A61M5/31576—Constructional features or modes of drive mechanisms for piston rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/50—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for preventing re-use, or for indicating if defective, used, tampered with or unsterile

Definitions

  • the present invention relates to a therapeutic material injection syringe for injecting a therapeutic material into the body by using the air pressure inside the syringe.
  • the drug delivery system minimizes the side effects of conventional methods and maximizes the therapeutic effect of the medicines to efficiently deliver the required amount of drug into the body. It means a formulation designed to be delivered to.
  • needle-based injections are the most popular because of their stability and efficiency.
  • Drug delivery systems using needles allow accurate and efficient drug administration, but can cause the risk of infection due to needle-phobia and reuse in the user, and can generate large amounts of medical waste. There is a problem. In particular, pediatric diabetics, who have to take drugs at all times, such as pediatric diabetes, complain of pain and pain caused by injection.
  • piezoelectric actuator injections inject liquid drugs at high speed, thereby penetrating the skin tissue and injecting the drug into the body.
  • Piezoelectric actuator injections were first developed in the 1930s and have been used to deliver many kinds of drugs and vaccines, such as macromolecule insulin and growth hormone, into the human body.
  • piezoelectric actuator injection may cause splash back, and may cause instability in a user because the exact dose of the penetrating drug and the depth of penetration of the drug are not known accurately.
  • piezoelectric actuator injection causes considerable pain.
  • the microjet injector may use a bio-lithical method of directly accelerating microparticles, a drug jet delivery method of injecting the drug into a jet, and a method of penetrating the drug into the body with a laser-guided shock wave.
  • the microproject injector using the laser-guided shock wave has a functional defect in which the edge of the separator and the vicinity of the center of the separator are easily damaged since the method of rapidly expanding the separator is a component.
  • Microjet injectors cause less pain than piezoelectric actuator injections, but have a limitation in that the high price increases the burden on the user.
  • One embodiment of the present invention by adjusting the inflow of air by opening and closing the inhalation valve, to provide a therapeutic material injection syringe for injecting a therapeutic material into the body by using a method of increasing the pressure inside the syringe. have.
  • One embodiment of the present invention is to provide a syringe for injecting a therapeutic material that can deliver a therapeutic material to the subcutaneous tissue in the body without causing pain.
  • an object of the present invention is to provide a syringe for injecting a therapeutic material to prevent diseases and infections that may occur by reusing the syringe.
  • an embodiment of the present invention is to provide a syringe for injecting a therapeutic material of low cost, high efficiency by using a method using the air pressure inside the syringe, without using a separate device.
  • a syringe assembly coupled to a therapeutic material injection syringe which has a hollow cylindrical shape, includes a fixed jaw line in the form of an internal protrusion, and is divided into an upper portion and a lower portion based on the fixed jaw line.
  • the insert is inserted into the housing and the housing, the insert is fixed to the jawline, and provides a syringe assembly, characterized in that it comprises a predetermined therapeutic material on the lower end.
  • the syringe assembly the needle through hole is formed at the other end of the syringe assembly, and further comprises a needle exposed through the needle through hole exposed to the outside of the syringe assembly. It features.
  • the fixing jaw line further comprises a projection
  • the insert further comprises a yaw groove
  • the yaw groove is characterized in that seated on the projection.
  • a therapeutic material injection syringe for injecting a therapeutic material into the body by the operation of the pressure and the piston of the air
  • the syringe assembly coupled to one end of the syringe assembly, the inflow of air by the air inlet
  • an inhalation valve for controlling discharge, one end of the inhalation valve, the barrel having a hollow cylindrical shape, and a plunger inserted into one end of the barrel to linearly move the inside of the barrel.
  • the syringe assembly is characterized in that the body assembly is detachably coupled to one end.
  • the plunger is characterized in that it comprises a pusher for manipulating the inside of the barrel to move linearly.
  • the plunger is characterized in that it comprises a push rod located between the presser and the sealing member, extending to the opening of the barrel and the inhalation valve.
  • the syringe used once is configured to have a structure that cannot be reused, and thus has an advantage of preventing diseases and infections that may occur by reusing the syringe.
  • FIG. 1 is a view showing the configuration of a syringe for injecting a therapeutic substance according to an embodiment of the present invention.
  • FIG. 2 is a cross-sectional view of a body assembly according to an embodiment of the present invention.
  • FIG 3 is a cross-sectional view of a syringe assembly according to one embodiment of the invention.
  • FIG. 4 is a cross-sectional view of an insert inserted into the syringe assembly according to one embodiment of the present invention.
  • FIG. 5 is a cross-sectional view of the needle adapter according to an embodiment of the present invention.
  • FIG. 6 is a view illustrating a process of filling a therapeutic material using a syringe for injecting a therapeutic material according to an embodiment of the present invention.
  • FIG. 7 is a view showing a process of removing the air inside the syringe for injecting a therapeutic material according to an embodiment of the present invention.
  • FIG. 8 is a view showing a process in which air is introduced into the therapeutic material injection syringe according to an embodiment of the present invention.
  • FIG. 9 is a view showing a process of injecting a therapeutic material inside the syringe for injecting a therapeutic material according to an embodiment of the present invention to the outside.
  • first, second, A, and B may be used to describe various components, but the components should not be limited by the terms. The terms are used only for the purpose of distinguishing one component from another.
  • the first component may be referred to as the second component, and similarly, the second component may also be referred to as the first component.
  • each component, process, process, or method included in each embodiment of the present invention may be shared within a range that is not technically contradictory.
  • FIG. 1 is a view showing the configuration of a syringe for injecting a therapeutic substance according to an embodiment of the present invention.
  • a syringe 100 for injecting a therapeutic material includes a main body assembly 110, a syringe assembly 120, and a needle adapter 130.
  • the body assembly 110 regulates the air inflow inside the syringe 100 and at the same time increases the air pressure inside the syringe 100 by performing a piston movement.
  • the syringe assembly 120 is detachably coupled to the other end of the body assembly 110.
  • the syringe assembly 120 includes a space into which the therapeutic material is introduced, and when the air pressure inside the syringe 100 is maximized by the body assembly 110, the therapeutic material is injected to the outside.
  • the needle adapter 130 is detachably coupled to the other end of the syringe assembly 120 and introduces a therapeutic material into the syringe assembly 120.
  • FIG. 2 is a cross-sectional view of a body assembly according to an embodiment of the present invention.
  • the body assembly 110 includes an inhalation valve 210, a barrel 220, and a plunger 230 inserted into the barrel 220.
  • Inhalation valve 210 may be detachably coupled to the other end of the barrel 220, the coupling method may be variously changed.
  • the inhalation valve 210 controls the inflow of air into the barrel 220 and the syringe assembly 120 by performing an opening / closing operation of introducing or exporting air using an air inlet (not shown). As the air inlet (not shown) is opened or closed by the rotation of the inhalation valve 210, air is injected or discharged into the syringe 100.
  • the inhalation valve 210 includes contact members 212 and 214.
  • the inhalation valve 210 is coupled to the other end of the barrel 220 and one end of the syringe assembly 120.
  • the contact members 212 and 214 have an inhalation valve 210 having the barrel 220 and the syringe assembly 120. ), So that it can be closely contacted without gaps.
  • the contact members 212 and 214 may be made of a rubber material having soft and elastic properties, but are not limited thereto.
  • the barrel 220 is implemented in a cylindrical shape having a hollow therein, and the opening 222 disposed at the other end of the barrel 220 may be used as a passage of the push rod 232 when the plunger 230 is inserted. .
  • the inhalation valve 210 is coupled to the coupling portion 224 located at the other end of the barrel 220.
  • the barrel 220 includes a flange 226 and a through hole 228.
  • the flange 226 may be disposed at one end of the barrel 130 to be used as a gripping element or a supporting member when the user manipulates the syringe 100.
  • a locking device (not shown) may be provided on an upper surface (+ y-axis direction) of the flange 226.
  • a locking device serves to fix the plunger 220 so that it no longer moves.
  • the through hole 228 has an opening having a predetermined diameter, so that the plunger 230 can be inserted into the through hole 228.
  • the diameter of the plunger 230 is implemented to be smaller than the diameter of the through hole 228 of the barrel 220. Accordingly, the plunger 230 enters the through hole 134 of the barrel 130 and moves linearly inside the barrel 130.
  • the plunger 230 includes a push rod 232, a sealing member 234, and a push rod 236.
  • the other end of the plunger 230 is provided with a push rod 232 in the form of a thin rod.
  • the pusher 232 moves up and down by pulling or pressing the pusher 236.
  • the push rod 232 passes through the opening 222 of the barrel 220, passes through the opening 216 of the inhalation valve 210, and comes into contact with an insert (not shown) inside the syringe assembly 120. Push out).
  • the sealing member 234 is formed of a material having ductility and elasticity, such as rubber or urethane, so that the outer circumferential surface may be in close contact with the inner surface of the barrel 220.
  • the sealing member 234 may be inserted into the barrel 220 to block the treatment material from flowing into or flowing back into the barrel 220.
  • One end of the plunger 230 is provided with a presser 236.
  • the user may hold the presser 236 to perform a piston operation to move the plunger 230 up and down.
  • the presser bar 236 When the user pulls the presser bar 236 in the body direction (+ y-axis direction), the air pressure inside the syringe 100 is reduced, and a therapeutic material (not shown) flows into the syringe assembly 120.
  • a therapeutic material (not shown) flows into the syringe assembly 120.
  • the presser 236 the air inside the syringe 100 is compressed to the maximum. Movement of the presser 236 is performed in conjunction with the opening and closing operation of the inhalation valve 210, the embodiment will be described in detail with reference to Figs.
  • FIG 3 is a cross-sectional view of a syringe assembly according to one embodiment of the invention.
  • the syringe assembly 120 may be embodied in a cylindrical shape having a hollow therein, and may be divided into an upper end 122 and a lower end 124 based on the fixing jaw line 314.
  • the syringe assembly 120 includes an engaging portion 310, an insert 312, a jawline 314, a housing 316, and a needle 322.
  • One end of the syringe assembly 120 is provided with a coupling portion 310.
  • the coupling part 310 may be screwed with the inhalation valve 210, but the coupling method may be changed.
  • the other end of the syringe assembly 120, the needle adapter 130 is detachably coupled.
  • the insert 312 may be inserted into the housing 316, and may be configured to have a recess (not shown) of the insert 312 mounted on a protrusion (not shown) of the fixed jaw line 314.
  • the jawline 314 prevents the insert 312 from moving to the lower end 124 of the syringe assembly 120. Detailed description of the insert 312 will be described with reference to FIG.
  • FIG. 4 is a cross-sectional view of an insert inserted into the syringe assembly according to one embodiment of the present invention.
  • the insert 312 may be configured to be inserted into the syringe assembly 120.
  • the tip of the insert 312 is predetermined to be easily fixed to the fixing jaw line 314. It may be implemented in a predetermined shape having an angle.
  • the length of the insert 312 may vary depending on the dose of the therapeutic material. That is, when the short length insert 312 is inserted into the syringe assembly 120, the dose of the therapeutic material flowing into the lower end 124 is increased. On the contrary, when the relatively long insert 312 is inserted, the volume of the lower end portion 124 is reduced as compared to when the short insert 312 is inserted, thereby reducing the dose of the therapeutic material introduced.
  • the insert 312 ejects the therapeutic material to the outside by the pressure of the air inside the syringe 100 and the piston manipulation of the body assembly 110. As described above, the insert 312 is fixed to the fixed jaw line 314. However, when the user locks the inhalation valve 210 and pulls the presser bar 236 in order to introduce the therapeutic material into the lower end 124, the insert 312 is moved from the fixed jaw line 314 to the upper end 122 by the pressure difference. Pushed). In addition, by the user opening the inhalation valve 210 and pressing the presser 236 of the main assembly 110, the pusher 232 contacts the insert 312 and fixes the insert 312 by the fixed jaw line ( At the same time as the 314, and removes the air introduced into the lower portion (124).
  • the insert 312 sprays the therapeutic material introduced into the lower portion 124 to the outside. While the inhalation valve 210 is still open, the user pulls the presser bar 236 again to introduce air into the barrel 220 and the upper end 122. When the user switches the inhalation valve 210 to the locked state in the inflow state of air, the air pressure inside the syringe 100 increases, and accordingly, the insert 312 receives air pressure. At this time, the user presses the pusher 236 to make contact with the push rod 232 and the insert 312 so that the insert 312 can be separated from the fixed jaw line 314.
  • the insert 312 in response to the pressure of the air of the barrel 220 and the upper end 122 and the contact 232, the insert 312 ejects the therapeutic material to the outside.
  • the operation of the insert 312 according to the operation of the body assembly 110 will be described sequentially with reference to FIGS. 6 to 9.
  • the needle 322 extends to the needle through hole 320 provided in the syringe assembly 120 to be exposed to the outside.
  • the length of the needle may be of a length that is as deep as the depth to the subcutaneous tissue located in the skin, or may be configured to be in contact with the subcutaneous tissue located in the skin. This is to reach the subcutaneous tissue directly with the injection needle.
  • the needle 320 according to the embodiment of the present invention is implemented in a shorter length than the general needle, the depth of the needle 320 is penetrated into the user's skin is about 0.5 ⁇ 1.0mm. Therefore, when the needle 320 is inserted into the body, the user hardly feels the pain.
  • the needle 320 is only penetrated to a depth of the subcutaneous tissue, the therapeutic material passed through the needle 320 by the strong force inside the syringe 100 is injected into the subcutaneous tissue, so that the therapeutic material is bounced or It can be transmitted completely to the subcutaneous tissue without being pushed out.
  • the injection needle 320 inserted into the body should not be reused for loss of function or infection prevention.
  • a needle protection cap (not shown) may be provided at the other end of the lower end 124 of the syringe assembly 120.
  • the needle protective cap (not shown) has a sufficient space to accommodate the needle 322, it may be configured in a structure that can be coupled to the other end of the lower end 124 of the syringe assembly 120.
  • FIG. 5 is a cross-sectional view of the needle adapter according to an embodiment of the present invention.
  • the needle adapter 130 includes a coupling part 410 and an injection liquid filling part 412.
  • the interior of the coupling portion 410 may be implemented in a structure that can be screwed with the other end of the syringe assembly 120.
  • the injection liquid filling unit 412 introduces a therapeutic material into the syringe assembly 120.
  • the injection liquid filling unit 412 may be embodied in the form of a pointed tip, it may be configured in the form having a hollow so that the therapeutic material can pass.
  • the user manipulates the body assembly 110 to insert the injection liquid filling part 412 into an ampoule containing the therapeutic material, and then manipulates the body assembly 110 to fill the therapeutic material into the syringe assembly 120 by pressure. To be possible. A detailed process of filling the therapeutic material into the syringe assembly 120 will be described later with reference to FIG. 6.
  • FIG. 6 is a view illustrating a process of filling a therapeutic material using a syringe for injecting a therapeutic material according to an embodiment of the present invention.
  • the user switches the inhalation valve 210 to the locked state.
  • the inhalation valve 210 is switched to the locked state, air inflow to the outside is blocked.
  • the upper portion of the syringe assembly 120 including the barrel 220 is sealed based on the fixing jaw line 314 of the syringe assembly 120.
  • the user pulls the presser bar 236.
  • the insert 312 fixed to the jawline 314 by the pressure difference inside the syringe assembly 120 is pushed to the upper end 122 of the syringe assembly 120, the lower end of the syringe assembly 120 ( The therapeutic material 510 flows into 124.
  • the dose of the therapeutic substance 510 to be injected into the body may be adjusted according to the length of the insert 312.
  • FIG. 7 is a view showing a process of removing the air inside the syringe for injecting a therapeutic material according to an embodiment of the present invention.
  • the user separates the syringe adapter 130 from the syringe assembly 120.
  • the user inhales to allow the air inside the syringe 100 to be discharged.
  • the valve 210 is switched from the locked state to the open state.
  • the user then presses the pusher 236 so that the plunger 230 faces the other end of the barrel 220. Accordingly, the insert 312 is pushed in the direction of the lower end 124 of the syringe assembly 120 by the push rod 232 to be seated on the fixed jaw line 314, and removes the air introduced into the lower end 124.
  • FIG. 8 is a view showing a process in which air is introduced into the therapeutic material injection syringe according to an embodiment of the present invention.
  • the user pulls the push rod 236 with the inhalation valve 210 open to inject the therapeutic material 510 to the outside using the pressure of air. Accordingly, air is introduced into the upper end 122 and the barrel 220 of the syringe assembly 120. That is, the amount of air in the upper end 122 and the barrel 220 of the syringe assembly 120 increases, which is then provided to the insert 312.
  • FIG. 9 is a view showing a process of injecting a therapeutic material inside the syringe for injecting a therapeutic material according to an embodiment of the present invention to the outside.
  • the user switches the inhalation valve 210 to the locked state so that the air introduced into the upper portion of the syringe assembly 120 and the barrel 220 is not discharged to the outside.
  • the air inlet 218 is blocked by the inhalation valve 210, and the inside of the syringe 100 is sealed with the air pressure increased.
  • the syringe 100 does not have a reinforcing material or an auxiliary material such as a gas filling chamber or an elastic member for injecting the therapeutic material 510, and uses the pressure of air to effectively operate the body.
  • the therapeutic material 510 may be injected into it.
  • the injection needle 322 is inserted into the body of the user to deliver the therapeutic material 510 to the subcutaneous tissue.
  • Needle 320 is completely delivered to the therapeutic material 510 to the subcutaneous tissue.
  • the therapeutic material 510 does not bounce or leak out.
  • the syringe assembly 120 cannot be reused because the insert 312 leaves the bottom 124 as it is used once, and the needle 322 is reused for functional reasons such as malfunction, infection and disease prevention. In principle, do not do it.

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

L'invention concerne une seringue pour injecter une substance thérapeutique. Selon un aspect du présent mode de réalisation, l'invention concerne un ensemble seringue couplé à une seringue pour injecter une substance thérapeutique, l'ensemble seringue comprenant : un boîtier ayant une forme cylindrique creuse et comprenant une protubérance de fixation sous la forme d'une saillie à l'intérieur de celui-ci, le boîtier étant divisé en une partie supérieure et une partie inférieure par rapport à la protubérance de fixation; et un insert inséré dans le boîtier, l'insert étant fixé à la protubérance de fixation et contenant une substance thérapeutique prédéterminée au niveau de la partie inférieure.
PCT/KR2019/003703 2018-04-06 2019-03-29 Seringue pour injecter une substance thérapeutique WO2019194475A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2018-0040177 2018-04-06
KR1020180040177A KR101883826B1 (ko) 2018-04-06 2018-04-06 치료물질 주입용 주사기

Publications (1)

Publication Number Publication Date
WO2019194475A1 true WO2019194475A1 (fr) 2019-10-10

Family

ID=63227877

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2019/003703 WO2019194475A1 (fr) 2018-04-06 2019-03-29 Seringue pour injecter une substance thérapeutique

Country Status (2)

Country Link
KR (1) KR101883826B1 (fr)
WO (1) WO2019194475A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101883826B1 (ko) * 2018-04-06 2018-08-01 이준욱 치료물질 주입용 주사기

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR970004843Y1 (ko) * 1993-09-08 1997-05-21 신현수 화살식 동물 주사기
US20140005610A1 (en) * 2010-11-16 2014-01-02 Harumi Kakiuchi Dual chamber prefillable syringe and aripiprazole filled in syringe
KR101759272B1 (ko) * 2016-11-08 2017-07-19 진세훈 진피 재생용 주사기
KR101763753B1 (ko) * 2015-11-10 2017-08-01 메디브레인랩 주식회사 이중 주사기
KR101883826B1 (ko) * 2018-04-06 2018-08-01 이준욱 치료물질 주입용 주사기

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR970004843Y1 (ko) * 1993-09-08 1997-05-21 신현수 화살식 동물 주사기
US20140005610A1 (en) * 2010-11-16 2014-01-02 Harumi Kakiuchi Dual chamber prefillable syringe and aripiprazole filled in syringe
KR101763753B1 (ko) * 2015-11-10 2017-08-01 메디브레인랩 주식회사 이중 주사기
KR101759272B1 (ko) * 2016-11-08 2017-07-19 진세훈 진피 재생용 주사기
KR101883826B1 (ko) * 2018-04-06 2018-08-01 이준욱 치료물질 주입용 주사기

Also Published As

Publication number Publication date
KR101883826B1 (ko) 2018-08-01

Similar Documents

Publication Publication Date Title
US4507113A (en) Hypodermic jet injector
US20090105685A1 (en) Two Stage Jet Injection Device
JP3816842B2 (ja) 別個の薬物リザーバを有する無針ジェット式注入システム
FI68003B (fi) Laekemedelinjektor
WO2012121504A2 (fr) Appareil d'injection de médicaments
WO2019168277A1 (fr) Dispositif de commande d'alimentation en fluide médicinal et dispositif d'injection de liquide d'injection
KR20000076536A (ko) 약물 투여 방법 및 시스템
WO2016195200A1 (fr) Appareil d'injection de fluide pour stimulation de la peau
US20090292239A1 (en) Injector System for Needleless, High Pressure Delivery of a Medicament
WO2015142013A1 (fr) Dispositif d'injection de fluides médicinaux
WO2018026130A1 (fr) Appareil d'injection de médicament liquide capable d'injecter un fluide supplémentaire après l'achèvement de l'injection de médicament liquide.
JP2013514113A (ja) 注射器
CN1332721C (zh) 装有内含液态或半固态成分的药筒或管体的注射装置
US5049137A (en) Prepackaged syringe and catheter apparatus for deep administration of a fluid, and method of making same
WO2019194475A1 (fr) Seringue pour injecter une substance thérapeutique
WO2017082643A1 (fr) Seringue à deux chambres
CN109982733A (zh) 一种基于保护壳体的植入物/药剂注射系统
WO2014208919A1 (fr) Raccord médical pour jonctions de vaisseaux sanguins
EP0470977B1 (fr) Seringue
EP0556276A4 (fr)
WO2024032688A1 (fr) Appareil d'administration de médicament à appareil de protection automatique
WO2021153882A1 (fr) Appareil d'administration de médicament implantable pouvant être commandé manuellement
US20060058741A1 (en) Infusion apparatus for infusion bags
US6277091B1 (en) Assembly for the distribution of a pharmaceutical solution in a multi-dose vial into single-dose capsules for single use
CN109890440B (zh) 用于在一次注射中以控制量分开给药至少两个产品的注射管-连接器装置

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19781272

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19781272

Country of ref document: EP

Kind code of ref document: A1